Smith+Nephew launches APAC digital innovation hub

MedTech News: MedTech company Smith+Nephew has announced the opening of a major medical education and digital innovation centre covering the Asia-Pacific region.

The S+N Academy Singapore offers an engaging, immersive and interactive training environment for healthcare professionals from across the region to experience the latest products and technologies, and refine their techniques under the guidance of expert peers.

“One of the challenges for the medical technology sector is the need to train practitioners, and having an academy like this will help to upgrade surgeons’ skills,” said Saurabh Sharma, Senior Director for Medical Education and Societies at Smith+Nephew Asia Pacific.

Deepak Nath, Chief Executive Officer of Smith+Nephew, said “We are proud to open S+N Academy Singapore which will provide the right environment and tools for thought leaders to challenge the status quo, refining new technologies and surgical techniques to improve outcomes for patients. We look forward to welcoming healthcare professionals to experience this unique medical innovation experience.”

Opposition commits to investment in robotic surgery technology

S+N Academy Singapore includes a state-of-the-art digital operating suite of the future including handheld robotics, 4K arthroscopy towers, surgical navigation tools, live transmission capabilities and touch-screen interfaces. The digital experience is supported by a virtual reality simulation studio, tech-enabled teaching auditorium, and a professional broadcast studio where experts can record and live-stream surgical techniques to educate fellow healthcare professionals across the globe.

S+N Academy Singapore also has fully equipped surgical super-stations for hands-on procedural training across Smith+Nephew’s entire portfolio of orthopaedic reconstruction, trauma, robotics, sports medicine, ear, nose and throat and advanced wound management. It is expected that up to 3500 healthcare providers will attend in-person courses at S+N Academy Singapore every year by 2025, with another 5000 being trained through digital technology.

Myra Eskes, President APAC and Global Service, Smith+Nephew, stated “Smith+Nephew has a strong and successful business in Asia-Pacific and ambitious growth plans to provide our medical technology to more surgeons and nurses. It is impossible to overstate the importance of education and hands-on experience as we take customers on this journey, and the new Academy will be vital in improving access to the latest innovation to drive better clinical outcomes.”

As an added commitment to medical innovation, S+N Academy Singapore will partner on initiatives within the wider healthcare community, including collaboration with start-ups, early-stage investors and industry partners to support the development of new innovations, and medical institutions to utilise the latest training infrastructure.

Opening courses include peer-to-peer flagship programmes designed specifically for the Asia Pacific region under the brands INSPIRE for Sports Medicine, and ASPIRE for Orthopaedic Reconstruction and Robotics. These courses will feature 50 distinguished global faculty and provide peer-to-peer education to 200 healthcare professionals from Asia-Pacific. 

Central to Smith+Nephew’s commitment to medical education and improving patient outcomes is providing a comprehensive accessible learning environment tailored to the needs of the healthcare professional. Through the S+N Academy Singapore and other centres in the US and Europe, we are actively transforming the way we educate our customers around the world by surrounding them with leading-edge technology, clinical content and scientific data. 

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.